Showing results (41-50 of 308) with videos related to
Sort By:
Pageof 31
Thrombosis and Haemostasis|May 8, 2015
Significant excess of early deaths after prehospital ticagrelor: The ATLANTIC trial challengeVictor Serebruany, Vasily Cherepanov, Alexander DukhaninAmerican Journal of Therapeutics|September 23, 2009
Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery diseaseJonas Hallén, Dan Atar, Victor SerebruanyInternational Journal of Cardiology|September 5, 2015
The FDA report on vorapaxar in the elderly: A convoluted dilemmaVictor L Serebruany, Seth D FortmannJournal of Thrombosis and Thrombolysis|January 1, 1995
Effects of a Novel Leumedin NPC 15669 on Myocardial Stunning and Preconditioned Infarction Size in SwineHerzog, Gurbel, Vogel, et al.Current Treatment Options in Cardiovascular Medicine|April 26, 2006
The action of dipyridamole to prevent thrombosis: practical implications for the treatment and prevention of strokeChristopher D Booze, Victor L SerebruanyThrombosis and Haemostasis|January 10, 2009
Prasugrel development - claims and achievementsVictor Serebruany, Inna Shalito, Olga KopylevaCardiology|February 15, 2013
Exploring the ticagrelor-statin interplay in the PLATO trialJames J Dinicolantonio, Victor L SerebruanyInternational Journal of Cardiology|January 1, 2013
Exploring the reduction in myocardial infarctions in the PLATO trial: which patients benefited on ticagrelor vs. clopidogrel?James J DiNicolantonio, Victor L SerebruanyThrombosis and Haemostasis|May 13, 2014
Viewpoint: "underutilisation of novel antiplatelet agents--myths, generics, and economics"V L Serebruany, S D FortmannPageof 31